Market Cap 1.29B
Revenue (ttm) 1.05B
Net Income (ttm) 23.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 25.42
Profit Margin 2.28%
Debt to Equity Ratio 0.00
Volume 70,600
Avg Vol 198,894
Day's Range N/A - N/A
Shares Out 63.29M
Stochastic %K 73%
Beta N/A
Analysts Strong Sell
Price Target $24.00

Latest News on GRDN

U.S. IPO Weekly Recap: 3 Sizable Deals Trade Up

Sep 28, 2024, 1:00 AM EDT - 4 months ago

U.S. IPO Weekly Recap: 3 Sizable Deals Trade Up

BIOA BKV FLX FVR PC SAG SARO


Guardian Pharmacy shares rise 3% in lukewarm NYSE debut

Sep 26, 2024, 10:50 AM EDT - 4 months ago

Guardian Pharmacy shares rise 3% in lukewarm NYSE debut


Healthcare firm Guardian Pharmacy raises $112 mln in US IPO

Sep 25, 2024, 9:45 PM EDT - 4 months ago

Healthcare firm Guardian Pharmacy raises $112 mln in US IPO


Guardian Pharmacy Services' IPO Valuation Looks Pricey

Sep 18, 2024, 11:46 AM EDT - 4 months ago

Guardian Pharmacy Services' IPO Valuation Looks Pricey


Guardian Pharmacy targets up to $974 mln valuation in US IPO

Sep 16, 2024, 12:33 PM EDT - 4 months ago

Guardian Pharmacy targets up to $974 mln valuation in US IPO


Guardian Pharmacy Services Launches U.S. IPO Effort

Oct 4, 2023, 1:16 PM EDT - 1 year ago

Guardian Pharmacy Services Launches U.S. IPO Effort


Guardian Pharmacy Services IPO Registration Document (S-1)

Oct 3, 2023, 5:03 PM EDT - 1 year ago

Guardian Pharmacy Services IPO Registration Document (S-1)